Diagnostic tool measuring pulse wave velocity as an indicator of arterial stiffness and cardiovascular health status. Provides objective assessment of vascular function through non-invasive pulse wave recording methodology.
Manufactured by
South Korea
Harvey Cardio Co., Ltd. – Innovating Cardiovascular Disease Screening Through Precision Technology Havey Cardio is setting a new standard in cardiovascular and cerebrovascular screening through our proprietary Pulse Wave Transit Time Ratio (PWR) analysis technology. 1. Technological Innovation: Unmatched Precision - Traditional Pulse Wave Velocity (PWV) methods often suffer from measurement errors depending on the patient’s body type or the practitioner’s technique. We have overcome these limitations by developing a technology that analyzes pulse wave data based on time ratios alone, eliminating the need for distance measurements. This breakthrough has been clinically validated, achieving a high diagnostic accuracy of approximately 82% in sensitivity and specificity. 2. Practical Innovation: Accessibility and Ease of Use - Equipped with our self-developed, high-sensitivity digital pressure sensors, our solution enables the simultaneous, accurate, and convenient measurement of pulse waves from multiple body points. We provide an environment where cardiovascular health can be managed easily not only in specialized general hospitals but also in primary care clinics, making preventive screening more accessible than ever. 3. Future Innovation: Synergy Between AI and Expertise - Our robust R&D ecosystem is led by executives with extensive experience in the pharmaceutical and healthcare industries, alongside a dedicated team of Ph.D. researchers in biomedical engineering. We are currently advancing a next-generation diagnostic platform that utilizes Artificial Intelligence (AI) simulations to detect subtle anomalies in pulse wave signals. Our Vision: Following our certification as a Venture Business and the official recognition of our Corporate R&D Center in 2025, Harvey Cardio is now poised for a major leap forward. Our mission is clear: to contribute to global health by developing innovative methods for the early detection and prevention of cardiovascular diseases, ensuring a healthier life for all humanity.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
DAEYOMEDI Co., Ltd.
South Korea · 2 relevant products
Nanjing Kejin Industrial LLC
China · 1 relevant product
Cardiex Limited
China · 3 relevant products
SOT Sonotechnik Austria Angio Experience GmbH
Austria · 3 relevant products
Tianjin Tianzhong Yimai Technology Development Co., Ltd.
China · 1 relevant product
See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
10 of 10 closest product alternatives
DAEYOMEDI Co., Ltd. · South Korea
Diagnostic platform for analyzing pulse wave characteristics to evaluate cardiovascular parameters, vascular elasticity, and age-related vascular changes. Detects cardiac arrhythmias and provides arterial stiffness assessment.
DAEYOMEDI Co., Ltd. · South Korea
Diagnostic tool that correlates applied pressure with pulse pressure response, generating graphical analysis for vascular assessment. Evaluates vascular compliance and elasticity characteristics.
Nanjing Kejin Industrial LLC · China
An arterial stiffness detection device that measures arterial elasticity and stiffness parameters for cardiovascular risk assessment. The system provides non-invasive evaluation of arterial compliance and vascular function.
Cardiex Limited · China
Digital vascular biomarker platform for arterial health screening and remote cardiovascular monitoring. Enables point-of-care risk stratification, early disease detection, and progression tracking through non-invasive assessment of arterial stiffness and vascular health status.
SOT Sonotechnik Austria Angio Experience GmbH · Austria
Vascular diagnostic test analyzing pulse wave parameters to assess arterial stiffness and cardiovascular health status.
Cardiex Limited · China
Clinical assessment tool evaluating arterial health and identifying patients at elevated risk for cardiovascular, metabolic, renal, and neurological diseases. Generates objective vascular biomarker data to guide clinical decision-making and patient management.
Tianjin Tianzhong Yimai Technology Development Co., Ltd. · China
A pulse diagnosis instrument representing the first version of the company's pulse diagnostic technology. This device is designed to assist in traditional Chinese medicine pulse assessment and diagnosis.
SOT Sonotechnik Austria Angio Experience GmbH · Austria
Optical diagnostic test measuring pulse oscillations to assess peripheral vascular function and arterial compliance.
SOT Sonotechnik Austria Angio Experience GmbH · Austria
Non-invasive optical measurement technique for assessing arterial pressure and peripheral blood pressure distribution.
Cardiex Limited · China
CONNEQT Pulse is a digital vascular biomarker platform for point-of-care arterial health screening and remote patient monitoring. It enables risk stratification, early disease detection, and progression monitoring by evaluating arterial stiffness as an indicator of cardiovascular and metabolic disease onset. The system generates clinically relevant data to support informed treatment decisions and accelerate drug development.
© 2026 Suplivia · Home · Browse Products